These conditions include cardiovascular disease (such as coronary artery disease, stroke, life-threatening arrhythmias, congestive heart failure, or untreated hypertension), advanced arteriosclerosis, hyperthyroidism, glaucoma, psychiatric agitation or psychosis, recent or concurrent MAOI therapy (within 14 days), history of drug abuse, pregnancy, breastfeeding, pediatric patients under 16, and concurrent use of other weight-loss medications
The PlexusDx Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R genesall linked to gastrointestinal response speed and appetite regulation
Amantadine-dyazide interaction
These drugs mimic a natural hormone that helps control blood sugar, reduce appetite, and slow digestion